SynthesisHernia : the journal of hernias and abdominal wall surgery2026
Robotic-assisted versus laparoscopic esophageal hiatal hernia and anti-reflux surgery: A comprehensive systematic review and meta-analysis.
Synthesis in Hernia : the journal of hernias and abdominal wall surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe comparison between robotic-assisted (RS) and laparoscopic anti-reflux surgery (LS) remains clinically relevant due to widespread adoption of robotic techniques without clear evidence of superior outcomes. This study aims to evaluate both approaches in terms of efficacy, safety, and cost.
methodsAdhering to PRISMA guidelines, we systematically searched in Medline, Embase, Web of Science, China National Knowledge Infrastructure, and Wanfang Data Knowledge Service Platform (2000-2025) for randomized controlled trials (RCTs) and observational studies comparing RS and LS in adults. Pooled analyzes utilized random- or fixed-effects meta-analysis models. Meta-regression, cumulative meta-analysis, and subgroup analyzes were conducted to enhance conclusion precision. Sensitivity analyzes assessed result robustness.
resultsThe systematic review included 38 studies (5 RCTs and 33 cohort studies) with a pooled population of 550,175 patients. For the primary outcome, no significant difference was observed in overall postoperative complications between RS and LS (RR = 0.85, 95% CI: 0.60-1.20). Among secondary outcomes, RS was associated with longer overall operative times (WMD = 19.81 min, 95% CI: 11.15-28.47 min); however, when only skin-to-skin operative time was analyzed, the difference was not statistically significant (WMD = 11.90 min, 95% CI: -7.75 to 31.55 min). RS demonstrated higher costs (WMD = $2,958.97, 95% CI: $1820.74-4,097.19) versus LS. No statistically significant differences were observed in blood loss, length of stay, intraoperative complications, recurrence, reoperation, or postoperative anti-reflux medication requirements. Cumulative meta-analysis demonstrated stable and consistent differences over time, indicating the early emergence of robust evidence.
conclusionRS showed comparable outcomes to LS in complications, blood loss, recurrence, reoperation, and postoperative medication requirements. RS was associated with higher costs compared to LS. Although overall operative time was longer with RS, subgroup analysis revealed no statistically significant difference in skin-to-skin surgical time between the two approaches. RS had higher costs. Comprehensive evaluations indicate that RS and LS yield analogous outcomes in terms of safety and efficacy for GERD. However, RS is linked to increased financial expenditure.
Indexed as
Identifiers
42397587What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.